Statistics
Publications
4
Citations
259
H-Index
4
Active since
2021
Steve E. Glenn is an author at Integrated DNA Technologies (United States) specializing in therapeutic genome editing, life sciences, and molecular biology.
Publications per year
2021–2024
4
4
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
Liyang Zhang, John A. Zuris, Ramya Viswanathan et al. · Nature Communications · 2021 · 172 citations · Full text
Boosting genome editing efficiency in human cells and plants with novel LbCas12a variants
Liyang Zhang, Gen Li, Yingxiao Zhang et al. · Genome biology · 2023 · 50 citations · Full text
1–4 of 4